Showing 2271-2280 of 2527 results for "".
- The American Optometric Association (AOA) Launches Nationwide Campaign to Make 2020 the Year of the Eye Examhttps://modernod.com/news/the-american-optometric-association-aoa-launches-nationwide-campaign-to-make-2020-the-year-of-the-eye-exam/2477227/The American Optometric Association (AOA) announced the official launch of the #2020EyeExam campaign to make eye health and vision care a national priority in 2020. The public awareness campaign underscores the importance of receiving an in-person comprehensive eye examination with an AOA doctor
- AAO: Survey Reveals Most Americans Know a Lot Less About Eye Health Than They Think They Dohttps://modernod.com/news/aao-survey-reveals-most-americans-know-a-lot-less-about-eye-health-than-they-think-they-do/2477222/A survey conducted by The Harris Poll has uncovered key gaps in American’s knowledge of eye health, and what they don’t know is putting them at risk of vision loss, according to an AAO news release. With the number of people affected by potentially blinding eye diseases expected to do
- Bausch + Lomb Secures Approval of Vyzulta in Mexicohttps://modernod.com/news/bausch-lomb-secures-approval-of-vyzulta-in-mexico/2477224/Nicox announced that its partner, Bausch + Lomb, has received approval for Vyzulta (latanoprostene bunod ophthalmic solution) 0.024% in Mexico. The approval in Mexico follows approvals of Vyzulta in the United States and Canada.
- Improved Reimbursement for Endoscopic Cyclophotocoagulation (ECP) when Combined with Cataract Surgeryhttps://modernod.com/news/improved-reimbursement-for-endoscopic-cyclophotocoagulation-ecp-when-combined-with-cataract-surgery/2477219/Beaver-Visitec International (BVI) expressed support for two new CPT codes and improved reimbursement for ECP when combined with cataract surgery. Up to 1 in 5 patients [1] undergoing cataract extraction suffers from glaucoma, and ECP remains an important option for ophtha
- Tarsus Pharmaceuticals Raises $60 Million for Demodex Blepharitis Drug Trialhttps://modernod.com/news/tarsus-pharmaceuticals-raises-60-million-for-demodex-blepharitis-drug-trial/2477213/Tarsus Pharmaceuticals announced the completion of $60 million in Series B financing. Tarsus will use the funds to initiate a phase 2b/3 trial in the United States of their lead product TP-03 for Demodex blepharitis and fuel phase 1 and 2 development of other clinical programs. An estimate
- EnChroma Introduces Line of Lenses for Low Vision and Age-Related Eye Conditionshttps://modernod.com/news/enchroma-introduces-line-of-lenses-for-low-vision-and-age-related-eye-conditions/2477199/EnChroma unveiled the “EnChroma Lx Series for Low Vision and Age-Related Eye Conditions,” a product line to address a rapidly growing category of visual challenges worldwide. The new line will be showcased at the Opti Munich 2020 International Trade Show for Optics and Design t
- Aerie Pharmaceuticals Announces Acceptance for Review of the Roclanda Marketing Authorization Application in Europehttps://modernod.com/news/aerie-pharmaceuticals-announces-acceptance-for-review-of-the-roclanda-marketing-authorization-application-in-europe/2477200/Aerie Pharmaceuticals announced that the European Medicines Agency (EMA) has accepted for review the marketing authorization application (MAA) for Roclanda (netarsudil and latanoprost ophthalmic solution) 0.02%/0.005%. Roclanda is currently marketed as Rocklatan in the United States, where it is
- Bausch Health Licenses Novaliq’s NOV03 Investigational Treatment For Dry Eye Disease Associated With Meibomian Gland Dysfunctionhttps://modernod.com/news/bausch-health-licenses-novaliqs-nov03-investigational-treatment-for-dry-eye-disease-associated-with-meibomian-gland-dysfunction/2477185/Bausch Health Companies and Novaliq have announced that Bausch Health has acquired an exclusive license for the commercialization and development in the United States and Canada of the investigational treatment NOV03 (perfluorohexy
- Staar Surgical Announces FDA IDE Clinical Study Approvalhttps://modernod.com/news/staar-surgical-announces-fda-ide-clinical-study-approval-2/2477164/Staar Surgical announced that the FDA, in a letter dated December 6, 2019, stated that it has determined that Staar has provided sufficient data to support initiation of a human clinical study in the United States of the EVO/EVO+ VISIAN Implantable Collamer Lens for Myopia, and EVO/EVO+ VISIAN To
- Novartis Harnessing AI in Amazon Partnership Aimed at Revamping Drug Manufacturing, Supplyhttps://modernod.com/news/novartis-harnessing-ai-in-amazon-partnership-aimed-at-revamping-drug-manufacturing-supply/2477142/Novartis announced Wednesday that it will work with Amazon’s cloud-computing unit to build a data and analytics platform that seeks to “re-invent” the way medicines are manufactured and delivered. “Four years ago, we started our journey with AWS (Amazon Web Servi